tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
KYMR is currently covered by 15 analysts with an average price target of $45.93. This is a potential upside of $12.56 (37.64%) from yesterday's end of day stock price of $33.37.
Kymera Therapeutics's activity chart (see below) currently has 28 price targets and 60 ratings on display. The stock rating distribution of KYMR is 38.64% HOLD and 61.36% BUY.
Analysts average stock forecasts to be materialized ratio is 51.12% with an average time for these price targets to be met of 211.85 days.
Highest price target for KYMR is $56, Lowest price target is $16, average price target is $45.93.
Most recent stock forecast was given by SRIKRIPA DEVARAKONDA from TRUIST on 01-Mar-2024. First documented stock forecast 15-Sep-2020.
Currently out of the existing stock ratings of KYMR, 17 are a HOLD (38.64%), 27 are a BUY (61.36%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
54
$18.79 (53.37%)
41
1 months 28 days ago
1/3 (33.33%)
$10.5 (24.14%)
112
Buy
56
$20.79 (59.05%)
43
2 months 2 days ago
2/8 (25%)
$12.43 (28.53%)
342
Buy
55
$19.79 (56.21%)
35
2 months 6 days ago
1/6 (16.67%)
$13.16 (31.45%)
99
Buy
47
$11.79 (33.48%)
42
2 months 6 days ago
1/3 (33.33%)
$5.16 (12.33%)
207
33
$-2.21 (-6.28%)
24
3 months 21 days ago
10/14 (71.43%)
$6.58 (24.91%)
205
What is KYMR (Kymera Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on KYMR (Kymera Therapeutics) with a proven track record?
Which analyst has the most public recommendations on KYMR (Kymera Therapeutics)?
Which analyst is the currently most bullish on KYMR (Kymera Therapeutics)?
Which analyst is the currently most reserved on KYMR (Kymera Therapeutics)?
